Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals
Go back to Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals| Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) | Delayed: 6.62 -0.17 (2.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.79 | 52 Week High | $5.95 | |||
| Open | $6.66 | 52 Week Low | $4.20 | |||
| Day High | $6.88 | P/E | 110.33 | |||
| Day Low | $6.47 | EPS | $0.06 | |||
| Volume | 28,148 | |||||
| (NASDAQ: TBPH) | Delayed: 17.06 -0.02 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.08 | 52 Week High | $38.92 | |||
| Open | $17.08 | 52 Week Low | $12.87 | |||
| Day High | $17.10 | P/E | N/A | |||
| Day Low | $17.06 | EPS | $0.00 | |||
| Volume | 251,661 | |||||
